BIOM-13. DNA METHYLATION MARKS GLUCOCORTICOID PATHWAY RESPONSE IN DEXAMETHASONE-TREATED BRAIN TUMOR PATIENTS

Dexamethasone (DEX) is routinely prescribed in brain tumor patients to limit vasogenic edema but may also exacerbate immunosuppression and adversely affect survival. The wide spectrum of dosing and individual variation in glucocorticoid (GC) response makes it difficult to assess the impact of DEX ex...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Wiencke, John, Molinaro, Annette, Warrier, Gayathri, Rice, Terri, Clarke, Jennifer, Taylor, Jennie, Wrensch, Margaret, Tamaki, Stanley, Lee, JiYoon, Hansen, Helen, McCoy, Lucie, Bracci, Paige, Salas, Lucas, Koestler, Devin, Christensen, Brock, Kelsey, Karl
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Biomarkers
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650309/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.013
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller